candesartan cilexetil has been researched along with natriuretic peptide, c-type in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Demura, H; Hagiwara, H; Hirose, S; Muraki, T; Naruse, K; Naruse, M; Shionoya, K; Tanabe, A; Tanaka, M; Yoshimoto, T | 1 |
1 other study(ies) available for candesartan cilexetil and natriuretic peptide, c-type
| Article | Year |
|---|---|
Angiotensin II-dependent down-regulation of vascular natriuretic peptide type C receptor gene expression in hypertensive rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Calcium Channel Blockers; Cells, Cultured; Dihydropyridines; Down-Regulation; Guanylate Cyclase; Hypertension; Male; Muscle, Smooth, Vascular; Natriuretic Peptide, C-Type; Nitrobenzenes; Piperazines; Proteins; Rats; Rats, Inbred SHR; Rats, Wistar; Receptors, Atrial Natriuretic Factor; RNA, Messenger; Tetrazoles | 1996 |